Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity Flow Analysis
1.6.2. Bottom-up Approach
1.7. List of Secondary Sources
1.8. List of Abbreviations
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. North America and Europe Preclinical Medical Device Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Complexity in product design
3.2.1.2. Strict approval norms
3.2.1.3. Increase in number of small medical device lacking in-house testing capabilities
3.2.1.4. Intense competition in medical device industry
3.2.2. Market restraint analysis
3.2.2.1. Legal and Regulatory Issues
3.3. Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. North America and Europe Preclinical Medical Device Testing Services Market: Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. North America and Europe Preclinical Medical Device Testing Services Market; Method Movement Analysis
4.3. North America and Europe Preclinical Medical Device Testing Services Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
4.4. Biocompatibility Tests
4.4.1. Biocompatibility tests market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Chemistry Test
4.5.1. Chemistry test market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Microbiology & Sterility Testing
4.6.1. Microbiology & sterility testing market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Bioburden Determination
4.6.2.1. Bioburden determination market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Pyrogen & Endotoxin Testing
4.6.3.1. Pyrogen & endotoxin testing market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Sterility Test and Validation
4.6.4.1. Sterility test and validation market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4.2. Ethylene Oxide (EO) gas sterilization
4.6.4.2.1. Ethylene oxide (EO) gas sterilization market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4.3. Gamma-irradiation
4.6.4.3.1. Gamma-irradiation market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4.4. E-beam sterilization
4.6.4.4.1. E-beam sterilization market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4.5. X-ray sterilization
4.6.4.5.1. X-ray sterilization market estimates and forecasts 2018 to 2030 (USD Million)
4.6.5. Antimicrobial Activity Testing
4.6.5.1. Antimicrobial activity testing market estimates and forecasts 2018 to 2030 (USD Million)
4.6.6. Others
4.6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Package Validation
4.7.1. Package validation market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. North America and Europe Preclinical Medical Device Testing Services Market: Regional Estimates & Trend Analysis
5.1. Regional Market Share Analysis, 2024 & 2030
5.2. Regional Market Dashboard
5.3. North America
5.3.1. North America Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.3.2. U.S.
5.3.2.1. Key country dynamics
5.3.2.2. Competitive scenario
5.3.2.3. Regulatory framework
5.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Canada
5.3.3.1. Key country dynamics
5.3.3.2. Competitive scenario
5.3.3.3. Regulatory framework
5.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.3.4. Mexico
5.3.4.1. Key country dynamics
5.3.4.2. Competitive scenario
5.3.4.3. Regulatory framework
5.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
5.4. Europe
5.4.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2. UK
5.4.2.1. Key country dynamics
5.4.2.2. Competitive scenario
5.4.2.3. Regulatory framework
5.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Germany
5.4.3.1. Key country dynamics
5.4.3.2. Competitive scenario
5.4.3.3. Regulatory framework
5.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. France
5.4.4.1. Key country dynamics
5.4.4.2. Competitive scenario
5.4.4.3. Regulatory framework
5.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Italy
5.4.5.1. Key country dynamics
5.4.5.2. Competitive scenario
5.4.5.3. Regulatory framework
5.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Spain
5.4.6.1. Key country dynamics
5.4.6.2. Competitive scenario
5.4.6.3. Regulatory framework
5.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
5.4.7. Denmark
5.4.7.1. Key country dynamics
5.4.7.2. Competitive scenario
5.4.7.3. Regulatory framework
5.4.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
5.4.8. Sweden
5.4.8.1. Key country dynamics
5.4.8.2. Competitive scenario
5.4.8.3. Regulatory framework
5.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
5.4.9. Norway
5.4.9.1. Key country dynamics
5.4.9.2. Competitive scenario
5.4.9.3. Regulatory framework
5.4.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Company Market Position Analysis, 2023
6.3. Company Profiles
6.3.1. SGS SA
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Service benchmarking
6.3.1.4. Strategic initiatives
6.3.2. Toxikon, Inc.
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Service benchmarking
6.3.2.4. Strategic initiatives
6.3.3. Eurofins Scientific
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Service benchmarking
6.3.3.4. Strategic initiatives
6.3.4. Pace Analytical Services LLC
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Service benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Intertek Group Plc
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Service benchmarking
6.3.5.4. Strategic initiatives
6.3.6. WUXI APPTEC
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Service benchmarking
6.3.6.4. Strategic initiatives
6.3.7. TÜV SÜD AG
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Service benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Sterigenics International LLC
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Service benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Nelson Labs
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Service benchmarking
6.3.9.4. Strategic initiatives
6.3.10. North American Science Associates, Inc.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Service benchmarking
6.3.10.4. Strategic initiatives
6.3.11. American Preclinical Services
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Service benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Charles River Laboratories International, Inc.
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Service benchmarking
6.3.12.4. Strategic initiatives
List of Tables
Table 1 List of Tables
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 5 North America and Europe Preclinical Medical Device Testing Services Market, by Region, 2018 - 2030 (USD Million)
Table 6 North America North America and Europe Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 8 U.S North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 9 Canada North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 10 Mexico North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 11 Europe North America and Europe Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
Table 12 Europe North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 13 UK North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 14 Germany North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 15 France North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 16 Italy North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 17 Spain North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 18 Denmark North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 19 Sweden North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
Table 20 Norway North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for Market share assessment
Fig. 8 Market formulation & validation
Fig. 9 North America and Europe Preclinical Medical Device Testing Services Market revenue, 2018 - 2030 (USD Million)
Fig. 10 North America and Europe Preclinical Medical Device Testing Services Market snapshot
Fig. 11 North America and Europe Preclinical Medical Device Testing Services Market driver impact
Fig. 12 North America and Europe Preclinical Medical Device Testing Services Market restraint impact
Fig. 13 North America and Europe Preclinical Medical Device Testing Services Market: Service takeaways (USD Million)
Fig. 14 North America and Europe Preclinical Medical Device Testing Services Market: Service movement analysis
Fig. 15 Biocompatibility Tests Market, 2018 - 2030 (USD Million)
Fig. 16 Chemistry Test Market, 2018 - 2030 (USD Million)
Fig. 17 Microbiology & Sterility Testing Market, 2018 - 2030 (USD Million)
Fig. 18 Bioburden Determination Market, 2018 - 2030 (USD Million)
Fig. 19 Pyrogen & Endotoxin Testing Market, 2018 - 2030 (USD Million)
Fig. 20 Sterility Test and Validation Market, 2018 - 2030 (USD Million)
Fig. 21 Ethylene Oxide (EO) gas sterilization Market, 2018 - 2030 (USD Million)
Fig. 22 Gamma-irradiation Market, 2018 - 2030 (USD Million)
Fig. 23 E-beam sterilization Market, 2018 - 2030 (USD Million)
Fig. 24 X-ray sterilization Market, 2018 - 2030 (USD Million)
Fig. 25 Antimicrobial Activity Testing Market, 2018 - 2030 (USD Million)
Fig. 26 Others Market, 2018 - 2030 (USD Million)
Fig. 27 Package Validation Market, 2018 - 2030 (USD Million)
Fig. 28 Regional Marketplace: Key takeaways
Fig. 29 Regional outlook, 2024 & 2030
Fig. 30 North America North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 31 U.S. North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 32 Canada North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 33 Mexico North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 34 Europe North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 35 UK North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 36 Germany North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 37 France North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 38 Italy North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 39 Spain companion animal Health Market, 2018 - 2030 (USD Million)
Fig. 40 Sweden North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 41 Denmark North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 42 Norway North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
Fig. 43 Market participant categorization
